Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study
- PMID: 24149174
- PMCID: PMC3887284
- DOI: 10.1038/bjc.2013.650
Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study
Abstract
Background: Black ethnic groups have a higher breast cancer mortality than Whites. American studies have identified variations in tumour biology and unequal health-care access as causative factors. We compared tumour pathology, treatment and outcomes in three ethnic groups in young breast cancer patients treated in the United Kingdom.
Methods: Women aged ≤ 40 years at breast cancer diagnosis were recruited to the POSH national cohort study (MREC: 00/06/69). Personal characteristics, tumour pathology and treatment data were collected at diagnosis. Follow-up data were collected annually. Overall survival (OS) and distant relapse-free survival (DRFS) were assessed using Kaplan-Meier curves, and multivariate analyses were performed using Cox regression.
Results: Ethnicity data were available for 2915 patients including 2690 (91.0%) Whites, 118 (4.0%) Blacks and 87 (2.9%) Asians. Median tumour diameter at presentation was greater in Blacks than Whites (26.0 mm vs 22.0 mm, P=0.0103), and multifocal tumours were more frequent in both Blacks (43.4%) and Asians (37.0%) than Whites (28.9%). ER/PR/HER2-negative tumours were significantly more frequent in Blacks (26.1%) than Whites (18.6%, P=0.043). Use of chemotherapy was similarly high in all ethnic groups (89% B vs 88.6% W vs 89.7% A). A 5-year DRFS was significantly lower in Blacks than Asians (62.8% B vs 77.0% A, P=0.0473) or Whites (62.8 B% vs 77.0% W, P=0.0053) and a 5-year OS for Black patients, 71.1% (95% CI: 61.0-79.1%), was significantly lower than that of Whites (82.4%, 95% CI: 80.8-83.9%, W vs B: P=0.0160). In multivariate analysis, Black ethnicity had an effect on DRFS in oestrogen receptor (ER)-positive patients that is independent of body mass index, tumour size, grade or nodal status, HR: 1.60 (95% CI: 1.03-2.47, P=0.035).
Conclusion: Despite equal access to health care, young Black women in the United Kingdom have a significantly poorer outcome than White patients. Black ethnicity is an independent risk factor for reduced DRFS particularly in ER-positive patients.
Figures



Comment in
-
Ethnic variation in breast cancer incidence and outcomes--the debate continues.Br J Cancer. 2014 Jan 7;110(1):4-6. doi: 10.1038/bjc.2013.775. Br J Cancer. 2014. PMID: 24398563 Free PMC article. No abstract available.
Similar articles
-
Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.J Natl Cancer Inst. 2013 Jul 3;105(13):978-88. doi: 10.1093/jnci/djt134. Epub 2013 May 30. J Natl Cancer Inst. 2013. PMID: 23723422
-
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.J Clin Oncol. 2015 Jul 10;33(20):2254-61. doi: 10.1200/JCO.2014.57.1349. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964252 Free PMC article.
-
Obesity and the outcome of young breast cancer patients in the UK: the POSH study.Ann Oncol. 2015 Jan;26(1):101-112. doi: 10.1093/annonc/mdu509. Epub 2014 Oct 30. Ann Oncol. 2015. PMID: 25361993
-
Survival differences in breast cancer among racial/ethnic groups: a population-based study.Cancer Detect Prev. 1999;23(6):463-73. doi: 10.1046/j.1525-1500.1999.99049.x. Cancer Detect Prev. 1999. PMID: 10571656
-
Breast lesions in black women.Pathol Annu. 1989;24 Pt 1:199-218. Pathol Annu. 1989. PMID: 2654837 Review.
Cited by
-
Relationship between ethnicity and stage at diagnosis in England: a national analysis of six cancer sites.BMJ Open. 2023 Jan 26;13(1):e062079. doi: 10.1136/bmjopen-2022-062079. BMJ Open. 2023. PMID: 36702581 Free PMC article.
-
Breast Cancer in Adolescents and Young Adults Less Than 40 Years of Age in Nigeria: A Retrospective Analysis.Int J Breast Cancer. 2022 Jul 29;2022:9943247. doi: 10.1155/2022/9943247. eCollection 2022. Int J Breast Cancer. 2022. PMID: 35936820 Free PMC article. Review.
-
Guidelines on Lifestyle Changes and Breast Cancer-where are we up to and how does this Apply to Black Women with Breast Cancer.Curr Oncol Rep. 2025 Jun 28. doi: 10.1007/s11912-025-01691-1. Online ahead of print. Curr Oncol Rep. 2025. PMID: 40579648 Review.
-
Obesity and triple-negative-breast-cancer: Is apelin a new key target?J Cell Mol Med. 2020 Sep;24(17):10233-10244. doi: 10.1111/jcmm.15639. Epub 2020 Jul 17. J Cell Mol Med. 2020. PMID: 32681609 Free PMC article.
-
Validation of the 8th edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients.Aging (Albany NY). 2020 Apr 22;12(8):7549-7560. doi: 10.18632/aging.103111. Epub 2020 Apr 22. Aging (Albany NY). 2020. PMID: 32320950 Free PMC article.
References
-
- Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Shah M, Ingle S, Greenberg D, Earl HM, Dunning AM, Pharoah PD, Caldas C. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen. Breast Cancer Res. 2010;12:R64. - PMC - PubMed
-
- Ademuyiwa FO, Olopade OI. Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev. 2003;22:47–53. - PubMed
-
- Antman K, Amato D, Wood W, Carson J, Suit H, Proppe K, Carey R, Greenberger J, Wilson R, Frei E., III Selection bias in clinical trials. J Clin Oncol. 1985;3:1142–1147. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous